Methods & Compositions for the Activation of Gamma-delta T-cells
Country:
US
Docket No:
436313-000394
Publication Number:
11,519,006
Patent Expiry:
01/13/2037
Claims Scope:
Patent issued December 6, 2022.
Sequence Agnostic – Composition & Methods
Composition of an immunotherapy system with a therapeutic vector encoding shRNA or miRNA that inhibits FDPS and activates a GD T cell or comprises an envelope protein capable of infecting a cancer cell. Method of treating cancer with a vector encoding at least one shRNA or miRNA that inhibits FDPS.
